Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
On May 13, 2026, Park Dental Partners, Inc. (the “Company”)
issued a press release on the Company’s website announcing its first quarter 2026 financial results for the reporting period ended
March 31, 2026. On May 14, 2026, the Company will host its quarterly earnings conference call, which will be accessible to the
public.
A copy of the Company’s press release is furnished as Exhibit 99.1
and is attached to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into
any filings under the Securities Act of 1933, as amended.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
Exhibit 99.1
Park Dental Partners Announces First Quarter 2026 Results
FOR IMMEDIATE RELEASE
Minneapolis, Minn. — May 13, 2026 — Park Dental Partners, Inc.
(NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,”
“our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026.
Summary financial results are listed below and in the accompanying supplemental financial tables.
(Unaudited,
in millions, except per share data, and Doctor counts)
| |
|
Three Months
Ended
March 31, |
|
| |
|
2026 |
|
|
2025 |
|
|
Change |
|
| Revenue |
|
$ |
62.7 |
|
|
$ |
59.0 |
|
|
|
6.2 |
% |
| Gross Margin |
|
$ |
6.4 |
|
|
$ |
9.9 |
|
|
|
(35.3 |
)% |
| Gross Margin percentage |
|
|
10.2 |
% |
|
|
16.7 |
% |
|
|
(650 |
)bps |
| Net Income (Loss) |
|
$ |
(0.4 |
) |
|
$ |
1.6 |
|
|
|
(124.9 |
)% |
| Diluted EPS |
|
$ |
(0.09 |
) |
|
$ |
0.88 |
|
|
$ |
(0.97 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Adjusted
Gross Margin(a) |
|
$ |
12.2 |
|
|
$ |
11.9 |
|
|
|
2.6 |
% |
| Adjusted
Gross Margin Percentage(a) |
|
|
19.5 |
% |
|
|
20.2 |
% |
|
|
(70 |
)bps |
| Adjusted
EBITDA(b) |
|
$ |
4.7 |
|
|
$ |
5.5 |
|
|
|
(13.2 |
)% |
| Adjusted
EBITDA margin(b) |
|
|
7.6 |
% |
|
|
9.3 |
% |
|
|
(170 |
)bps |
| Adjusted
Diluted EPS(c) |
|
$ |
0.44 |
|
|
$ |
1.14 |
|
|
$ |
(0.70 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Same Practice Revenue Growth |
|
|
4.1 |
% |
|
|
1.2 |
% |
|
|
290 |
bps |
| Practicing Affiliated Doctors |
|
|
221 |
|
|
|
203 |
|
|
|
8.9 |
% |
| (a) | See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin
below |
| (b) | See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA
below |
| (c) | See Non GAAP Reconciliation of Earnings (Loss) Per Share to Adjusted
Earnings Per Share below |
Executive Commentary – Pete Swenson, Chief Executive Officer
and Chair of the Board of Directors
“We delivered a solid start to 2026, with revenue increasing
6.2% year over year, driven by strong same practice performance and continued patient demand. Results were consistent with our expectations
and reflect continued execution against our operating plan. We continue to invest in recruiting, staffing, and clinical capacity to support
long-term growth.
With strong liquidity and a flexible balance sheet, we remain well
positioned to execute on our growth strategy, including expanding current practices and adding new practices through disciplined acquisitions
and de novo expansion.”
Financial Results – First Quarter 2026
| · | Revenue increased 6.2% over the prior year’s comparable quarter to $62.7 million, due to increased patient visits and
growth in clinical hours, the impact of acquisitions, and reimbursement growth. Same practice revenue growth was 4.1%. Revenue from
acquisitions in the past 12 months contributed approximately $0.8 million in the quarter. |
| · | Total
General Practice revenue grew 6.4% over the prior year’s comparable quarter to $46.1
million. Total Multi-Specialty Practice revenue grew 5.7% to $16.6 million. |
| · | Cost
of services was $56.3 million, an increase of $7.1 million above the prior year’s comparable
quarter, driven primarily by share-based
compensation recorded in the quarter, and growth in doctors and team members. |
| · | General
and administrative costs were $7.8 million, an increase of $0.9 million above the prior year’s
comparable quarter. The primary driver of these increases was share-based compensation, acquisition-related
costs, and public company costs, net of lower IPO preparation costs related to our 2025 offering. |
| · | Net
loss was $(0.4) million, compared to net income of $1.6 million in the prior year comparable quarter,
primarily driven by increased salaries and benefits, and share-based compensation, partially
offset by revenue growth, tax benefits on share-based compensation, and operating leverage. |
| · | Adjusted
EBITDA was $4.7 million, or 7.6% of revenue, compared to $5.5 million, or 9.3% of revenue
in the prior year comparable quarter. |
| · | Adjusted
diluted earnings per share were $0.44 versus $1.14 in the prior year’s comparable quarter,
due primarily to the increase in shares issued and vested during the IPO. |
Affiliated Practice Updates
| · | As
of March 31, 2026, we supported 86 affiliated practices and 221 affiliated doctors. |
| · | First
quarter patient retention rate was 90.1%. |
| · | Patient
visits increased to 178,527 across our affiliated dental practices. |
| · | During
the first quarter our affiliated dental practices completed one general practice acquisition
in Tucson, Arizona, as previously announced on January 23, 2026. The acquired practices’
impact on revenues and net earnings was not material for the quarter. |
Balance Sheet, Liquidity, and Cash Flow
| · | Cash
and cash equivalents were $24.4 million as of March 31, 2026. |
| · | Total
debt outstanding was approximately $11.5 million as of March 31, 2026, and our $15 million
line of credit was undrawn at quarter end. |
| · | Total
shares outstanding were 4.5 million shares as of the end of the quarter. |
| · | We
generated $5.0 million in operating cash flow in the first quarter, a decrease of $0.8 million
compared to the prior year comparable quarter due primarily to changes in working capital. |
| · | First
quarter capital investments were $2.3 million. |
Full-Year 2026 Outlook
First quarter results were consistent with our expectations, and we
are maintaining our fiscal 2026 outlook range. Our outlook excludes the impact of any future practice affiliations or acquisitions that
have not yet closed. As a result, actual results may differ materially depending on the timing and number of future affiliations, de
novo practice openings, or acquisitions completed during the year.
| | |
Year Ending
December 31, 2026 | | |
Year Ended
December 31, 2025 | | |
Percent
Change | |
| ($ in millions) | |
(Outlook) | | |
(Actual) | | |
(At Midpoint) | |
| Revenue | |
| $254.0
– $258.0 | | |
$ | 244.5 | | |
| 4.7 | % |
| Adjusted EBITDA | |
| $21.0
– $23.0 | | |
$ | 22.0 | | |
| - | |
| Adjusted EBITDA margin | |
| 8.3%
- 8.9% | | |
| 9.0 | % | |
| | |
Our outlook includes 3.5% to 5.0% same practice revenue growth and
approximately $2 million recurring public company costs we expect to incur in 2026. The outlook assumes continued patient demand across
general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention
initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand and
labor market trends that could impact our outlook.
Conference Call
As announced on April 24, 2026, the Company will host a conference
call to discuss these results tomorrow morning, Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
A
live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s
website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited
time following the call.
About Park Dental Partners, Inc.
Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK)
is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company
provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment,
to its affiliated general and multi-specialty dental practices. The Company has 221 affiliated doctors across 86 practice locations in
three states. The Company’s clinical support team consists of approximately 990 hygienists, dental assistants, and patient care
coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception
has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind
our organization today.
Park Dental Partners is based in Roseville, Minnesota. For more information,
please visit parkdentalpartners.com.
Basis of Consolidation
In accordance with generally accepted accounting principles in the
United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative
resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations
and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the
affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.
Forward Looking Statements
Certain statements in this press release are “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives,
future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,”
“expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,”
“will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ
materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties,
such as:
| · | Regulatory
and compliance risk, including state dental corporate practice of dentistry and fee-splitting
restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare
and labor regulations; |
| · | Reimbursement
risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity,
enrollment and collections timing, and dependence on significant third-party payors; |
| · | Our
ability to identify, acquire, integrate and effectively support affiliated practices and
to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions; |
| · | Dependence
on affiliated dental practices and their clinical performance; our ability to attract, hire
and retain dentists, specialists and hygienists; and risks related to ownership transitions
of affiliated entities; |
| · | Competition
for patients and clinicians in our markets and the impact on patient volumes and staffing; |
| · | Macroeconomic
conditions, inflation and interest rates, and our geographic concentration, particularly
in the markets we operate. |
A forward-looking statement is neither a prediction nor a guarantee
of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly
disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.
Non-GAAP Financial Measures
This news release and the related conference call include presentation
of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the
Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition
because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for
the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends
and to gain an understanding of the comparative operating performance of the Company.
Please note that the Company has not provided the most directly comparable
GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included
in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing
the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort
due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal
settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially
significant, impact on our future GAAP financial results.
See Supplemental non-GAAP financial tables below for a reconciliation
of adjusted non-GAAP financial measures to GAAP.
Company Contact Information
Investor Contact:
Park Dental Partners Investor Relations Team
763-233-3377
ir@parkdentalpartners.com
Media Contact:
Park Dental Partners Media Relations Team
651-633-0500
marketing@parkdentalpartners.com
Supplemental Financial Tables
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
(in thousands, except share and per share amounts)
| | |
Three
Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| REVENUE | |
$ | 62,695 | | |
$ | 59,037 | |
| COST OF SERVICES | |
| | | |
| | |
| Salaries and benefits | |
| 41,895 | | |
| 35,637 | |
| Dental supplies and Laboratory fees | |
| 4,338 | | |
| 4,239 | |
| Office occupancy | |
| 4,285 | | |
| 4,004 | |
| Other practice expenses | |
| 3,834 | | |
| 3,405 | |
| Depreciation | |
| 1,963 | | |
| 1,896 | |
| TOTAL COST OF SERVICES | |
| 56,315 | | |
| 49,181 | |
| GROSS MARGIN | |
| 6,380 | | |
| 9,856 | |
| General and administrative expenses | |
| 7,840 | | |
| 6,928 | |
| Depreciation and amortization | |
| 420 | | |
| 378 | |
| OPERATING INCOME (LOSS) | |
| (1,880 | ) | |
| 2,550 | |
| INTEREST EXPENSE - NET | |
| (121 | ) | |
| (337 | ) |
| INCOME (LOSS) BEFORE TAX | |
| (2,001 | ) | |
| 2,213 | |
| PROVISION/(BENEFIT) FOR INCOME TAX | |
| (1,611 | ) | |
| 646 | |
| NET INCOME (LOSS) | |
$ | (390 | ) | |
$ | 1,566 | |
| EARNINGS (LOSS) PER SHARE: | |
| | | |
| | |
| Basic | |
$ | (0.09 | ) | |
$ | 0.88 | |
| Diluted | |
$ | (0.09 | ) | |
$ | 0.88 | |
| Basic weighted-average number of common
shares outstanding | |
| 4,383,073 | | |
| 1,783,352 | |
| Diluted weighted-average number of common
shares outstanding | |
| 4,383,073 | | |
| 1,783,352 | |
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)
(in thousands)
| | |
At
March 31, | | |
At
December 31, | |
| | |
2026 | | |
2025 | |
| ASSETS | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 24,372 | | |
$ | 25,185 | |
| Accounts receivable – net of allowance | |
| 6,819 | | |
| 6,991 | |
| Other current assets | |
| 6,531 | | |
| 5,726 | |
| Total current assets | |
| 37,722 | | |
| 37,902 | |
| OTHER ASSETS: | |
| | | |
| | |
| Property and equipment and lease assets | |
| 73,945 | | |
| 73,828 | |
| Goodwill and Intangible assets, nets | |
| 29,793 | | |
| 28,360 | |
| Other assets | |
| 38,397 | | |
| 38,093 | |
| Total other assets | |
| 142,135 | | |
| 140,281 | |
| TOTAL ASSETS | |
$ | 179,857 | | |
$ | 178,183 | |
| LIABILITIES AND DEFICIT | |
| | | |
| | |
| Accounts payable and other accrued liabilities | |
$ | 6,682 | | |
$ | 6,291 | |
| Payroll, benefits and short term deferred compensation | |
| 16,802 | | |
| 16,716 | |
| Current portion of debt and lease liabilities | |
| 8,730 | | |
| 8,606 | |
| Deferred Revenue and other current liabilities | |
| 3,084 | | |
| 4,120 | |
| Total current liabilities | |
| 35,298 | | |
| 35,733 | |
| LONG-TERM LIABILITIES: | |
| | | |
| | |
| Deferred compensation | |
| 67,569 | | |
| 68,417 | |
| Long-term debt and lease liabilities | |
| 51,016 | | |
| 51,744 | |
| Other long-term liabilities | |
| 537 | | |
| 486 | |
| Total long-term liabilities | |
| 119,122 | | |
| 120,647 | |
| TOTAL LIABILITIES | |
$ | 154,420 | | |
$ | 156,380 | |
| Total shareholders’ equity | |
$ | 25,437 | | |
$ | 21,803 | |
| TOTAL LIABILITIES AND SHAREHOLDERS’
EQUITY | |
$ | 179,857 | | |
$ | 178,183 | |
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
2025 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | | |
| | |
| Net income (loss) | |
$ | (390 | ) | |
$ | 1,566 | |
| Adjustments to reconcile net income
(loss) to net cash flows from operating activities: | |
| | | |
| | |
| Depreciation and amortization | |
| 2,383 | | |
| 2,274 | |
| Deferred income taxes | |
| (470 | ) | |
| — | |
| Change in cash surrender value of life
insurance | |
| 440 | | |
| 335 | |
| Noncash lease and loss on disposal of
equipment | |
| 31 | | |
| (15 | ) |
| Share based compensation | |
| 4,024 | | |
| — | |
| Changes in operating
assets and liabilities | |
| (992 | ) | |
| 1,699 | |
| Net cash flows from operating activities | |
| 5,026 | | |
| 5,859 | |
| NET CASH FLOWS USED IN INVESTING ACTIVITIES: | |
| | | |
| | |
| Purchases of property and equipment | |
$ | (2,305 | ) | |
$ | (2,420 | ) |
| Life insurance premiums paid | |
| (273 | ) | |
| (664 | ) |
| Payments for purchases of dental practices | |
| (1,595 | ) | |
| — | |
| Issuance of notes
to related parties | |
| (600 | ) | |
| — | |
| Net cash flows used in investing activities | |
| (4,773 | ) | |
| (3,084 | ) |
| CASH FLOWS USED IN FINANCING ACTIVITIES: | |
| | | |
| | |
| Dental practice purchase installment
payments | |
$ | (8 | ) | |
$ | (8 | ) |
| Net change in checks issued in excess
of cash balances | |
| (573 | ) | |
| (1,328 | ) |
| Net proceeds (payments) on debt and
capital leases | |
| (485 | ) | |
| (489 | ) |
| Cash paid for
Share Repurchase | |
| — | | |
| (154 | ) |
| Net cash flows
used in financing activities | |
| (1,066 | ) | |
| (1,979 | ) |
| NET CHANGE IN CASH AND CASH EQUIVALENTS | |
| (813 | ) | |
| 796 | |
| CASH AND CASH EQUIVALENTS – Beginning
of year | |
| 25,185 | | |
| 2,672 | |
| CASH AND CASH EQUIVALENTS - End of
year | |
$ | 24,372 | | |
$ | 3,468 | |
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF GROSS MARGIN TO ADJUSTED
GROSS MARGIN (unaudited)
(in thousands)
| | |
Three
Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| GROSS MARGIN | |
$ | 6,380 | | |
10.2 | % | |
$ | 9,856 | | |
16.7 | % |
| Addback: | |
| | | |
| | |
| | | |
| |
| Share based compensation | |
| 3,665 | | |
5.8 | % | |
| - | | |
0.0 | % |
| Restructuring
costs1 | |
| 37 | | |
0.1 | % | |
| 63 | | |
0.1 | % |
| Deferred compensation | |
| 160 | | |
0.3 | % | |
| 85 | | |
0.1 | % |
| Depreciation | |
| 1,963 | | |
3.1 | % | |
| 1,896 | | |
3.2 | % |
| ADJUSTED GROSS MARGIN | |
$ | 12,205 | | |
| | |
$ | 11,900 | | |
| |
| ADJUSTED GROSS MARGIN PERCENTAGE | |
| | | |
19.5 | % | |
| | | |
20.2 | % |
1 Restructuring costs primarily consist of expenses
incurred in connection with the Company’s initial public offering.
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED
EBITDA (unaudited)
(in thousands)
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
| | |
2025 | | |
| |
| NET INCOME (LOSS) | |
$ | (390 | ) | |
(0.6 | )% | |
$ | 1,566 | | |
2.7 | % |
| Addback: | |
| | | |
| | |
| | | |
| |
| Provision/(Benefit) for income tax | |
| (1,611 | ) | |
(2.6 | )% | |
| 646 | | |
1.1 | % |
| Interest expense, net | |
| 121 | | |
0.2 | % | |
| 337 | | |
0.6 | % |
| Depreciation and amortization | |
| 2,383 | | |
3.8 | % | |
| 2,274 | | |
3.9 | % |
| EBITDA | |
$ | 503 | | |
0.8 | % | |
$ | 4,823 | | |
8.2 | % |
| Adjustments: | |
| | | |
| | |
| | | |
| |
| Share based compensation | |
| 4,024 | | |
6.4 | % | |
| - | | |
0.0 | % |
| Restructuring costs1 | |
| 58 | | |
0.1 | % | |
| 557 | | |
0.9 | % |
| Deferred compensation | |
| 160 | | |
0.3 | % | |
| 85 | | |
0.1 | % |
| ADJUSTED EBITDA | |
$ | 4,745 | | |
7.6 | % | |
$ | 5,465 | | |
9.3 | % |
1 Restructuring costs primarily consist of expenses
incurred in connection with the Company’s initial public offering.
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF EARNINGS (LOSS) PER SHARE
TO ADJUSTED EARNINGS PER SHARE (unaudited)
(in thousands, except share and per share amounts)
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
2025 | |
| EARNINGS (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: | |
$ | (390 | ) | |
$ | 1,566 | |
| Adjustments: | |
| | | |
| | |
| Share based compensation | |
| 4,024 | | |
| - | |
| Restructuring costs | |
| 58 | | |
| 557 | |
| Deferred compensation | |
| 160 | | |
| 85 | |
| Income
tax effect of the Adjustments1 | |
| (1,188 | ) | |
| (180 | ) |
| ADJUSTED NET INCOME ATTRIBUTABLE TO
COMMON STOCKHOLDERS | |
$ | 2,664 | | |
$ | 2,028 | |
| | |
| | | |
| | |
| Adjusted Weighted Average Diluted Shares -
Reconciliation | |
| | | |
| | |
| WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET LOSS PER
SHARE, DILUTED | |
| 4,383,073 | | |
| 1,783,352 | |
| ADJUSTED
WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED2 | |
| 6,059,839 | | |
| 1,783,352 | |
| | |
| | | |
| | |
| ADJUSTED DILUTED EARNINGS PER SHARE: | |
$ | 0.44 | | |
$ | 1.14 | |
1 Income tax effect is based on an estimated long-term
annual effective tax rate of 28% tax rate for the three months ended March 31, 2026 and March 31, 2025. The Company’s
estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used
in order to provide consistency across periods.
2 Includes an additional 1,584,666 of weighted average
dilutive shares and 92,100 of weighted average dilutive warrants for the three months ended March 31, 2026, that are excluded from
a GAAP perspective due to the Company’s net loss in that reporting period.
PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONSOLIDATED OPERATING METRICS (unaudited)
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
2025 | |
| Patient Visits1 | |
| 178,527 | | |
| 175,940 | |
| Same Practice Revenue Growth2 | |
| 4.1 | % | |
| 1.2 | % |
| Patient Retention Rate3 | |
| 90.1 | % | |
| 89.2 | % |
| Doctor Count4 | |
| 221 | | |
| 203 | |
1 A patient visit is counted when service is provided
to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps
us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences
decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making
processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies.
Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients
to complete their diagnosed dental treatment plans.
2 Same practice revenues represent total revenues for
same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and
which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate
how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand
for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition,
visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the
level of patient service provided inside and outside of the dental practices.
3 Patient retention rate is calculated by counting patients
that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having
been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients
who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology
is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an
active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring
nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate
levels of staffing, recruiting, advertising and facility expansion opportunities.
4 Dentists operating in one of our affiliated dental
practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over-quarter
change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making
relating to matters such as appropriate staffing levels and recruiting needs.
